Luitpold Venofer NDA Adds Historical Control To Address FDA Concerns
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Luitpold Pharmaceuticals addressed FDA concerns about baseline stability in pivotal trials for its injectable iron sucrose product Venofer by submitting historical control data, FDA review documents show.